Van Eck Associates Corp Bausch Health Companies Inc. Transaction History

Van Eck Associates Corp

$108 Billion
Q3 2025

A detailed history of Van Eck Associates Corp transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 115,490 shares of BHC stock, worth $725,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,490

Previous 131,226 11.99%

Holding current value

$725,277

Previous $874,000 14.76%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$5.71 - $8.34 $89,852 - $131,238	-15,736 Reduced 11.99%	115,490 $745,000
Q2 2025 Aug 14, 2025	SELL	$4.32 - $6.66 $1.45 Million - $2.24 Million	-335,926 Reduced 71.91%	131,226 $874,000
Q1 2025 May 15, 2025	BUY	$6.16 - $7.94 $1.5 Million - $1.94 Million	243,732 Added 109.09%	467,152 $3.02 Million
Q4 2024 Jan 29, 2025	SELL	$7.34 - $9.78 $879,684 - $1.17 Million	-119,848 Reduced 34.91%	223,420 $1.8 Million
Q3 2024 Oct 29, 2024	BUY	$5.22 - $8.26 $212,960 - $336,983	40,797 Added 13.49%	343,268 $2.77 Million

Q2 2024 Jul 31, 2024	BUY	$6.1 - $10.41 $69,411 - $118,455	11,379 Added 3.91%	302,471 $2.11 Million
Q1 2024 Apr 30, 2024	SELL	$7.77 - $10.61 $733,425 - $1 Million	-94,392 Reduced 24.49%	291,092 $3.09 Million
Q4 2023 Feb 05, 2024	SELL	$6.53 - $8.23 $782,117 - $985,731	-119,773 Reduced 23.71%	385,484 $3.09 Million
Q3 2023 Nov 08, 2023	SELL	$7.69 - $9.71 $809,749 - $1.02 Million	-105,299 Reduced 17.25%	505,257 $4.15 Million
Q2 2023 Aug 03, 2023	BUY	$5.72 - $8.8 $1.45 Million - $2.24 Million	254,075 Added 71.27%	610,556 $4.88 Million
Q1 2023 May 03, 2023	SELL	$6.28 - $9.85 $1.89 Million - $2.96 Million	-301,015 Reduced 45.78%	356,481 $2.89 Million
Q4 2022 Feb 08, 2023	BUY	$6.09 - $7.93 $594,993 - $774,761	97,700 Added 17.45%	657,496 $4.13 Million
Q3 2022 Oct 27, 2022	SELL	$4.58 - $9.21 $927,381 - $1.86 Million	-202,485 Reduced 26.56%	559,796 $3.86 Million
Q2 2022 Aug 03, 2022	BUY	$7.06 - $23.63 $2.24 Million - $7.51 Million	317,964 Added 71.56%	762,281 $6.37 Million
Q1 2022 May 10, 2022	BUY	$21.6 - $27.79 $422,301 - $543,322	19,551 Added 4.6%	444,317 $10.2 Million
Q4 2021 Jan 26, 2022	BUY	$23.0 - $29.01 $1.9 Million - $2.4 Million	82,819 Added 24.22%	424,766 $11.7 Million
Q3 2021 Nov 03, 2021	BUY	$25.04 - $30.06 $2.39 Million - $2.87 Million	95,547 Added 38.78%	341,947 $9.52 Million
Q2 2021 Aug 10, 2021	SELL	$27.43 - $32.7 $5.81 Million - $6.93 Million	-211,849 Reduced 46.23%	246,400 $7.23 Million
Q1 2021 May 13, 2021	BUY	$21.37 - $34.38 $2.01 Million - $3.23 Million	94,057 Added 25.83%	458,249 $14.5 Million
Q4 2020 Feb 09, 2021	BUY	$15.31 - $21.12 $121,148 - $167,122	7,913 Added 2.22%	364,192 $7.58 Million
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $467,827 - $632,887	-31,440 Reduced 8.11%	356,279 $5.54 Million
Q2 2020 Aug 10, 2020	BUY	$13.31 - $20.51 $610,782 - $941,183	45,889 Added 13.42%	387,719 $7.09 Million
Q1 2020 May 12, 2020	BUY	$12.98 - $30.25 $790,702 - $1.84 Million	60,917 Added 21.69%	341,830 $5.3 Million
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $910,762 - $1.54 Million	48,214 Added 20.72%	280,913 $8.41 Million
Q3 2019 Nov 08, 2019	SELL	$20.88 - $25.66 $2.61 Million - $3.21 Million	-125,116 Reduced 34.97%	232,699 $5.08 Million
Q2 2019 Aug 07, 2019	BUY	$20.52 - $26.45 $43,543 - $56,126	2,122 Added 0.6%	357,815 $9.02 Million
Q1 2019 May 13, 2019	SELL	$20.23 - $26.29 $2.21 Million - $2.87 Million	-109,222 Reduced 23.49%	355,693 $8.79 Million
Q4 2018 Feb 12, 2019	SELL	$17.64 - $28.32 $891,966 - $1.43 Million	-50,565 Reduced 9.81%	464,915 $8.59 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $431,252 - $536,348	20,894 Added 4.22%	515,480 $13.2 Million
Q2 2018 Aug 13, 2018	BUY	$15.07 - $26.86 $7.45 Million - $13.3 Million	494,586 New	494,586 $11.5 Million

Others Institutions Holding BHC

# of Institutions

262

Shares Held

207M

Call Options Held

2.54M

Put Options Held

6.46M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.27B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Bausch Health Companies Inc. Transaction History